During the past decade, FLENI conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "FLENI" #1 sponsor was "Ionis Pharmaceuticals, Inc." with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Cephalon" with 1 trials sponsored and "Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "FLENI" #1 collaborator was "Heart and Stroke Foundation of Ontario" with 1 trials as a collaborator, "Ontario Ministry of Health and Long Term Care" with 1 trials as a collaborator and "Ontario Stroke Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "FLENI" are "Amyloidosis" (2 trials), "FAP" (2 trials), "Familial Amyloid Polyneuropathy" (2 trials), "TTR" (2 trials) and "Transthyretin" (2 trials). Many other conditions were trialed in "FLENI" in a lesser frequency.

Most popular intervention types in "FLENI" are "Drug" (8 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Inotersen" (3 trials), "Armodafinil" (1 trials), "Drug delivery system for administration of AP 12009" (1 trials) and "Eplontersen" (1 trials). Other intervention names were less common.

The vast majority of trials in "FLENI" are 11 trials for "All" genders.

Currently, there are NaN active trials in "FLENI". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in FLENI, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in FLENI, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

FLENI has several departments that took part in Clinical trials: "Instituto de Investigaciones Neurologicas Raul Carrea, FLENI" - 3 trials, "Instituto de Investigaciones Neurológicas Raul Carrea FLENI" - 2 trials